SEC Filing Analysis: Celularity Inc (CELU)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director received a routine, non-cash grant of 28,847 Restricted Stock Units (RSUs) as compensation.
• Market Impact: Neutral. This is a standard compensation event, not an open-market transaction reflecting insider sentiment.

Company Information

Field	Value
Company	Celularity Inc
Ticker Symbol	CELU
CIK	0001752828
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	LeVien Vincent
CIK	0002076464
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4/A
Transaction Date	2026-01-12
Transaction Code	A (Award)
Security Type	Class A Common Stock (RSUs)
Shares Involved	28,847
Price Per Share	$0.00
Total Value	$0
Shares Owned After	153,847
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	28,847
% of Shares Outstanding	Not Available
Post-Transaction Ownership	153,847 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The company's market capitalization is approximately $40 million. The grant has a transaction value of $0, making its direct financial impact negligible.
• Dilution Impact: As shares outstanding data is not available, a precise dilution calculation is not possible. However, grants of this nature are a common form of director compensation.
• Transaction Significance: The transaction is assessed as having low significance. It is a non-cash award for services rather than an investment decision based on market sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: RSU grants are a standard form of compensation and do not typically influence short-term stock price as they are not open-market transactions.

Volume & Sentiment

• Expected Volume Impact: None. This transaction does not affect trading volume.
• Sentiment Indicator: Neutral. The grant does not signal a bullish or bearish outlook from the insider.

Additional Context

Transaction Notes

• Footnote Details: The filing footnotes clarify that the transaction represents a grant of Restricted Stock Units (RSUs) under the company's 2021 Equity Incentive Plan. The RSUs vested immediately upon grant.